Incidence and predictors of postoperative delirium after cytoreduction surgery‐hyperthermic intraperitoneal chemotherapy: Methodological issues

Reply to comment on: Incidence and predictors of postoperative delirium after cytoreduction surgery‐hyperthermic intraperitoneal chemotherapy

“…We appreciate the interest in our work and the opportunity to respond to the comments and matters raised by Weng et al regarding our article on “Incidence and predictors of postoperative delirium after cytoreduction surgery‐hyperthermic intraperitoneal chemotherapy.” The study was conducted among a consecutive series of 136 prospectively included patients who underwent CRS‐HIPEC at our hospital. Twenty‐eight percent of our patients developed a postoperative delirium.…”